These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 13158198)
21. [Treatment of chronic myeloid leukemia by means of a new chemical antiblastic agent, 1-4-dimethylsulfonoxy-butane]. ESTEVEZ RA Prensa Med Argent; 1958 Apr; 45(16):1644-9. PubMed ID: 13601527 [No Abstract] [Full Text] [Related]
22. [Myleran in the treatment of chronic myelocytic leukemia]. KLIMA R; BEYREDER J; HERZOG E Wien Klin Wochenschr; 1954 Sep; 66(35-36):682-5. PubMed ID: 14348855 [No Abstract] [Full Text] [Related]
23. [Treatment of chronic myelocytic leukemia with myleran]. KANZOW U; WOLFERS H Medizinische; 1957 Oct; 2(40):1460-1; discussion 1461-2. PubMed ID: 13482894 [No Abstract] [Full Text] [Related]
25. [Experiences with sulfabutin in two cases of chronic myeloid leukemia]. JOERG M Wien Med Wochenschr; 1955 Jan; 105(2):55-6. PubMed ID: 14359991 [No Abstract] [Full Text] [Related]
26. [Immediate and remote results of treatment of patients with chronic myeloid leukosis with myelosan]. GUREVICH LI Sov Med; 1960 Oct; 24():84-8. PubMed ID: 13709851 [No Abstract] [Full Text] [Related]
27. [Myleran in therapy of chronic myeloid leukemia]. BRANCO F; DA GAMA MM J Soc Cienc Med Lisb; 1954; 118(8):459-66. PubMed ID: 14353594 [No Abstract] [Full Text] [Related]
28. [Myleran therapy of chronic myeloid leukemia]. BELER B; ERGUN N Turk Tip Cemiy Mecm; 1958 Apr; 24(4):205-8. PubMed ID: 13592964 [No Abstract] [Full Text] [Related]
29. Nitrogen balance as affected by neoplastic disease and its therapy. Watkin DM Am J Clin Nutr; 1961; 9(4):446-60. PubMed ID: 13783378 [No Abstract] [Full Text] [Related]
30. A case of chronic myeloid leukemia treated with a dimethylsulfonyl butanediol derivative. ERBA L Minerva Med; 1955 Feb; 46(13):420-1. PubMed ID: 14355905 [No Abstract] [Full Text] [Related]
31. [Myleran in chronic myeloid leukemia; importance of systematic maintenance therapy]. CLOSON J; CONTENT M Rev Belg Pathol Med Exp; 1956 Nov; 25(5):413-30. PubMed ID: 13421050 [No Abstract] [Full Text] [Related]
33. Busulfan in the treatment of chronic myelocytic leukemia. The effect of long term intermittent therapy. HAUT A; ABBOTT WS; WINTROBE MM; CARTWRIGHT GE Blood; 1961 Jan; 17():1-19. PubMed ID: 13712355 [No Abstract] [Full Text] [Related]
34. [Sistemic reticulosarcomatosis as a consequence of prolonged roentgen rays and radiophosphorus therapy of chronic myeloid leukemia]. KNIAZEVA GD Arkh Patol; 1954; 16(2):36-9. PubMed ID: 13159672 [No Abstract] [Full Text] [Related]
36. First results of dopane therapy of chronic myeloid leukemia and of certain malignant tumors. VISHNIAKOVA EG Vopr Onkol; 1958; 4(5):569-72. PubMed ID: 13625640 [No Abstract] [Full Text] [Related]
37. [Total bone marrow aplasia caused by uncontrolled treatment with dimethanesulfonoxybutane in a case of chronic myelocytic leukemia]. PAOLINO W; BACHI C Minerva Med; 1960 Oct; 51():3450-3. PubMed ID: 13732563 [No Abstract] [Full Text] [Related]
38. [Data on an unusual acute transformation in a case of chronic myeloid leukemia following dimethylsulfonoxy-butane therapy]. GIGANTE D Clin Ter; 1958 May; 14(5):469-85. PubMed ID: 13561522 [No Abstract] [Full Text] [Related]
39. [Recommendations for the cytogenetic management of chronic myeloid leukemia (CML) proposed by the French Group for Cytogenetic Hematology]. Dastague N; Pathol Biol (Paris); 2004 Jun; 52(5):238-40. PubMed ID: 15217702 [No Abstract] [Full Text] [Related]
40. Progress and strategies for patients with relapsed and refractory acute myeloid leukemia. Litzow MR Curr Opin Hematol; 2007 Mar; 14(2):130-7. PubMed ID: 17255790 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]